New eye test may detect signs of Alzheimer’s disease
The scientists have developed a new eye test that non-invasively scans the retina and detects beta-amyloid protein — a hallmark of Alzheimer’s disease. Amyloid beta are amino acids and main component of the amyloid plaques found in the brains of Alzheimer patients. The experimental technology scans the retina using techniques that can identify beta-amyloid protein deposits that mirror those in the brain. The findings revealed a 4.7-fold increase in retinal plaque burden in patients with Alzheimer’s, compared to controls. “As a developmental outgrowth of the central nervous system that shares many of the brain’s characteristics, the retina may offer a unique opportunity to easily and conveniently detect and monitor Alzheimer’s disease,” said a scientist. Accumulations of neurotoxic beta-amyloid protein can be detected with positron emission tomography, or PET scans, and analysis of cerebrospinal fluid, but these are invasive, inconvenient and costly, making them impractical for routine screening and follow-up evaluation.
However, the new technique uses an auto-fluorescence imaging system that includes a specialised ophthalmic camera and sophisticated image processing software. The tests non-invasively detects presumed amyloid deposits in retinas of living patients. In addition, the tests showed retinal plaque clusters, or “hot spots”, containing the most toxic forms of beta-amyloid with specific distribution patterns in superior peripheral regions that were previously unexplored. “Findings from this study strongly suggest that retinal imaging can serve as a surrogate biomarker to investigate and monitor Alzheimer’s disease (early in the process),” noted the Associate Professor.
However, the new technique uses an auto-fluorescence imaging system that includes a specialised ophthalmic camera and sophisticated image processing software. The tests non-invasively detects presumed amyloid deposits in retinas of living patients. In addition, the tests showed retinal plaque clusters, or “hot spots”, containing the most toxic forms of beta-amyloid with specific distribution patterns in superior peripheral regions that were previously unexplored. “Findings from this study strongly suggest that retinal imaging can serve as a surrogate biomarker to investigate and monitor Alzheimer’s disease (early in the process),” noted the Associate Professor.
this is only for your
information, kindly take the advice of your doctor for medicines,
exercises and so on.
https://gscrochetdesigns.blogspot.com. one can see my crochet creations https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
Labels: accumulation, Alzheimer's, beta amyloid plaques, brains, detects, neurotoxic amyloid plaques, non-invasive tests, PET scan, protein deposits, retina
0 Comments:
Post a Comment
<< Home